News

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...
BeiGene's Tevimbra gets a highly sought after recommendation.
The Committee for Medicinal Products for Human Use (CHMP) has recommended that Imfinzi be used in combination with ...
RHHBY's Itovebi combo wins CHMP backing for PIK3CA-mutated breast cancer, showing strong survival benefits in phase III ...
Novo Nordisk has won a Committee for Medicinal Products for Human Use (CHMP) endorsement for a higher-dose version of its diabetes drug liraglutide that can be used to treat obesity. The Danish ...
The new infusion for maple syrup urine disease is for patients who cannot have an oral or enteral branched-chain amino ...
GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has ...
(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...
The autologous immunotherapy consists of the patient’s own T cells engineered to express a chimeric antigen receptor that ...
Basel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has ...
NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Autolus Therapeutics' autologous CD19-directed CAR T-cell therapy Aucatzyl ...
The oncology company said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion of its treatment in combination with gemcitabine and ...